Sort
15,842 grants matching “pancreatic cancer”
P-1: Immunotherapy of Pancreatic Adenocarcinoma
$135,215Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2010 · CA
University of Minnesota Clinical Center for the Study of Pancreatic Disease
$135,173Melena D. Bellin · University Of Minnesota · U01 · FY2023 · DK
Cellular mechanisms and therapeutic possibilities of inhibiting oncogenic KRAS
$135,108Andrew L Wolfe · University Of California, San Francisco · K99 · FY2019 · CA
Investigating Cellular Communication in the Tumor Microenvironment in Pancreatic Cancer
$135,097Nina G Steele · University Of Michigan At Ann Arbor · K99 · FY2021 · CA
P-1: Immunotherapy of Pancreatic Adenocarcinoma
$135,097Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2009 · CA
Career Development Program
$135,097Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2018 · CA
Washington Obstetric-Fetal Pharmacology Research Unit
$135,000Menachem Miodovnik · Georgetown University · U10 · FY2008 · HD
PROCEED + DETECT Year 9 supplement patient care costs
$135,000Christopher E Forsmark · University Of Florida · U01 · FY2023 · DK
Consortium for the study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Consortium â Pittsburgh Clinical Center
$134,997Dhiraj Yadav · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · DK
Computational and theoretical fluid mechanics modeling for transport in dense tumors
$134,805Saikat Basu · North Dakota State University · P20 · FY2024 · GM
Computational and theoretical fluid mechanics modeling for transport in dense tumors
$134,785Saikat Basu · North Dakota State University · P20 · FY2023 · GM
The role of Sin1 in Kras-driven cancer
$134,714Pau Castel · New York University School Of Medicine · R00 · FY2022 · CA
Inflamation and the Risk of Endometrial Cancer
$134,490Akila Viswanathan · Dana-Farber Cancer Inst · K07 · FY2009 · CA
Inflamation and the Risk of Endometrial Cancer
$134,490Akila Viswanathan · Dana-Farber Cancer Inst · K07 · FY2010 · CA
Inflamation and the Risk of Endometrial Cancer
$134,490Akila Viswanathan · Dana-Farber Cancer Inst · K07 · FY2008 · CA
ROLES OF OST3/6 THIOL OXIDOREDUCTASES IN N-LINKED PROTEIN GLYCOS/REDOX HOMEOSTAS
$134,456Dmitri Fomenko · University Of Nebraska Lincoln · P20 · FY2011 · RR
Proteomic Analysis of Protein Prenylation
$134,400Purdue University West Lafayette · R21 · FY2005 · CA
Proteomic Analysis of Protein Prenylation
$134,400Purdue University West Lafayette · R21 · FY2004 · CA
Novel RNase-based Immunotoxin for CD74-positive B-cell Malignancies
$134,285Chien Hsing K. Chang · Immunomedics, Inc. · R43 · FY2007 · CA
F-18 FDG Peptides for Pretargeted PET Imaging of Pancrea
$134,285Immunomedics, Inc. · R43 · FY2005 · EB
Comprehensive Systematic Evidence Review of the Clinical Utility of Polygenic Risk Scores for Hepatocellular Carcinoma and Pancreatic Cancer Risk Assessment
$134,250Raphael E. Pollock · Ohio State University · P30 · FY2023 · CA
Human Tissue Research and Logistics Core
$134,135Ralph H Hruban · Johns Hopkins University · P50 · FY2009 · CA
Development of Novel Markers for Melanoma Progression
$133,987Byungwoo Ryu · Nevada Cancer Institute · K01 · FY2010 · CA
TGFBeta1 signaling and radiation response in pancreas CA
$133,962University Of Kentucky · R01 · FY2004 · CA
Determining how cancer cachexia influences gluconeogenesis
$133,955Yichi Zhang · Massachusetts Institute Of Technology · K99 · FY2025 · CA